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Purpose: The purpose of this study was to develop an aortic aneurysm (AA) model with a 
predictable tendency for rupture for the evaluation of the efficacy of  endovascular 
prostheses in preventing rupture and their long-term outcome after implantation. 
2VIethods: An infrarenal AA measuring two to three times the diameter of the proximal aorta 
was created in 18 dogs with a fuU-thickness patch ofjejunum. Seven dogs were aUowed 
to survive without aneurysm exclusion. In 11 dogs the aneurysm was immediately 
excluded with a stented 8 mm Dacron graft mounted in a 14F delivery system introduced 
through the femoral artery with aortographic guidance. The pressure differential between 
the aorta and the excluded aneurysm was measured, and angiography, necropsy, and 
histologic examination were performed at 3- and 6-month survival. 
Results: All animals survived aneurysm implantation. Without aneurysm exclusion, six 
dogs died of rupture within 1 to 6 days of  surgery. In three dogs the exclusion failed 
because of graft-to-aorta size mismatch or misplacement demonstrated on angiography 
and by a low pressure differential between the aorta and the aneurysm ( < 5 mm Hg); all 
three dogs died of rupture within 4 days. In eight dogs the aneurysm was successfully 
excluded on the basis of  angiography results, with a mean aorta-to-aneurysm pressure 
differential of 51 mm Hg. Two dogs were kiUed at i and 6 days after surgery because of 
paraplegia produced by graft thrombosis because of kinking but without evidence of 
aneurysm rupture. Six dogs survived on a long-term basis, and angiography and necropsy 
performed at 3 and 6 months revealed patent grafts without migration, reduction in 
aneurysm size, no flow in the excluded lumbar arteries in five ofsix animals, and complete 
incorporation of Dacron graft and stents. No evidence of graft infection was found in any 
animal. The survival rate was significantly bet-ter (p < 0.023) in dogs with successfuUy 
excluded aneurysms (n = 6) compared with that in dogs without exclusion or with failed 
aneurysm exclusion (n = 7). 
Conclusion: This aneurysm model demonstrates that without effective aneurysm exclusion 
all animals die ofrupture and that successfully placed endovascular prostheses can prevent 
AA rupture with long-term graft patency and stability. Endovascular aortic Dacron grafts 
in dogs undergo complete incorporation at 3 months from implantation. This aneurysm 
model is useful for the evaluation of endovascular devices designed for the treatment of 
AAs. (J VASC SURG 1995;22:306-15.) 
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The technical fcasibility of  abdominal aortic 
aneurysm (AAA) exclusion with endovascular pros- 
theses has been proven in studies on animals and 
human beings. 1-8 The first intraluminal aortic aneu- 
rysm exclusion in an animal model was reported by 
Balko et al)  in 1987. Since then, several investigators 
have reproduced successful cxperiences with a variety 
of  endovascular grafts and stents for the exclusion of  
aneurysms in animals 2-6 and in human beings. 8'9 The 
effectiveness o f  endovascular stented grafts in pre- 
venting aneurysm rupture is intuitively appealing; 
höwever, it has not  yet been demonstrated in 
experimental or long-term clinical studies. Further- 
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Fig. 1. Operative photo of infrarenal aortic aneurysm created by sumring patch of small 
intestine to anterior longitudinal aortotomy. Aneurysms created in this fashion typically 
measured two to three times diameter of adjacent proximal aorta. To right, inferior mesenteric 
and lumbar arteries are temporarily controlled with hemoclips that were removed at completion 
of procedure. 
more, many questions regarding the short- and 
long-term effects of these new devices remain unan- 
swered. The initial feasibility studies performed in 
animals used aneurysm models made of prosthetic 
material without any tendency for rupture. The 
purpose of this study was to develop an animal model 
of aortic aneurysm made of autogenous tissue with a 
predictable tendency for rupture to test the effective- 
ness of endovascular exclusion grafts in preventing 
rupture and to smdy the long-term behavior of 
endovascular prostheses in vivo. 
MATERIAL AND METHODS 
This animal study was approved by the Institu- 
tional Animal Care and Use Committee of the 
University of North Carolina, Chapel Hill. Before 
the long-term survival smdies the surgical technique 
for creation of an infrarenal aortic aneurysm was 
tested in acute studies in six mongrel dogs. Intestinal 
patches were sutured to an anterior, longitudinal, 
infrarcnal aortotomy, and the animals were observed 
under anesthesia for 4 to 6 hours and immediately 
killed. A number of intestinal patches were treated 
with two different concentrations of glutaraldehyde 
(1% and 4%) to assess their macroscopic character- 
istics and surgical handling, in the event that un- 
treated frcsh intestine would not be able to sustain 
aortic pressure without immediate rupture. This 
preliminary study demonstrated that hemostasis 
around the intestinal patch was complete and that 
immediate aneurysm rupture did not occur with 
untreated or treated intestine. 
Eighteen male mongrel dogs weighing 22.7 to 
38.6 kg were anesthetized with intravenous sodium 
pentobarbital and maintained with isoflurane under 
endotracheal intubation. The day before surgery the 
animals started receiving a clear liquid diet and were 
given 500 mg neomycin and 250 mg erythromycin 
by mouth. One gram of intravenous cefotetan was 
given beforc incision. With a sterile technique, a 
midline laparotomy was performed, a segment of 
proximal jejunum mcasuring ó to 8 cm in length was 
resected, and the jejunum was reanastomosed end- 
to-end with 4-0 polyglyconate. The resected jejunum 
was opencd along the mesenteric border and 
trimmed to form an elliptical patch of 4 to 5 cm in 
length and 3 to 4 cm in width and then placed in a 
solution of 100 ml normal saline solution with 80 mg 
gentamycin and 500 mg neomycin for approximately 
45 minutes. Heparin was given intravenously (75 
IU/kg), and the aorta was cross-clamped below the 
renal arteries and above the iliac bifurcation. The 
lumbar and inferior mesenteric arteries were tem- 
porarily controlled with hemoclips that were re- 
moved on completion of the aortic patch suture. A 
4 cm longitudinal aortotomy was performed in the 
anterior aspect of the aorta just proximal to the 
inferior mesenteric artery. The jejunal patch was 
then anastomosed to the aortotomy with a running 
4-0 polypropylene sumre. This resulted in an aortic 
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Fig. 2. Uncrimped Dacron grafts (Cooley Very Soft) sutured to Gianturco Z stents at both 
ends were used for endovascular exclusion of surgically created infrarenal aortic aneurysms in 
dogs. 
aneurysm measuring two to three times the diameter 
of the normal adjacent aorta, with a 2 to 3 cm neck of 
normal aorta proximal and distal to the aneurysm 
(Fig. 1). The retroperitoneal layer was reapproxi- 
mated over the aneurysm after hemostasis was com- 
plete. The abdominal fascia was closed with running 
0 polyglyconate, and the skin was closed with absorb- 
able suture. In seven dogs an aortic aneurysm was 
created without endovascular exclusion, and the dogs 
were kept alive long term. Four aneurysms were cre- 
ated with unaltered intestinal patch autografts, 
whereas three were constructed with glutaraldehyde- 
treated intestinal homografts. Two of the glutaralde- 
hyde-treated intestinal patches were preserved in 4% 
glutaraldehyde for 48 hours, and one intestinal patch 
was preserved in 1% glutaraldehyde for ó hours. 
In 11 dogs the aneurysm creation was followed by 
immediate endovascular graft exclusion. In these 
animals, after creation of the aneurysm, the abdomen 
was temporarily closed with skin staples, and the 
right femoral artery was surgically exposed. The 
common, superficial, and deep femoral arteries were 
controlled with vessel loops, and an additional 
intravenous dose of heparin was given (150 
units/kg). A transverse arteriotomy was performed in 
the common femoral artery and, under fluoroscopic 
guidance (OEC 9400 G arm; Diasonics, Milpitas, 
Calif.), a 0.018-inch diameter guide wire was ad- 
vanced into the abdominal aorta. An angiogram 
catheter was introduced over the wire, and a sub- 
traction angiogram was obtained by use of Reno- 
grafin-ó0 contrast (5 ml per injection). The anatomy 
of the renal arteries, aneurysm, and aortic bifurcation 
was clearly defined to guide placement of the 
prosthesis. The angiogram catheter was removed, 
and the guide wire left in place across the aneurysm. 
Uncrimped Cooley very soft straight Dacron grafts 
(Meadox Medicals, Inc., Oakland, N.J.) measuring 
70 to 75 mm in length and 8 mm in diameter (one 
graft measured 10 mm in diameter) were secured 
proximally and distally to Gianturco Z stents (Cook 
Inc. Bloomington, Ind.), with 6-0 polypropylene 
sutures. The proximal stent measured 17 mm in 
length and 20 mm in maximal expansion diameter 
and had three sharp prongs pointing distally and 
outward. Distally, 15 × 15 mm Gianturco stents 
without prongs were sccured to the Dacron grafts 
in a similar fashion (Fig. 2). The stented graft was 
mounted on a coaxial carrier without preclotting 
and compressed into an introducer sheath with a 
previously described system, s The delivery system 
was advanced over the guide wire under fluoro- 
scopic guidance. With the previously obtained an- 
giographic road map, the proximal stent was ad- 
vanced to the aortic segment between the renal 
arteries and the aneurysm. The sheath over the 
graft-stent system was then withdrawn, and the 
proximal stent deployed. Next, the distal steht was 
deployed by further withdrawing the sheath and 
allowing it to expand distal to the aneurysm sac, 
in accord with the technique previously described 
by Chuter et al.s A completion angiogram was 
obtained to document immediate aneurysm exclu- 
sion. The skin staples were removed from the 
abdomen, the aneurysm and aorta were examined, 
and the site of the prosthesis was determined by 
palpation. Blood pressures were measured imme- 
diately after exclusion without reversal of heparin 
in the aorta proximal and distal to the prosthesis 
via the angiographic catheter, and pressure within 
the aneurysm sac but outsidc the prosthesis was 
recorded with a 20-gauge needle connected to a 
pressure transducer. The femoral arteriotomy was 
closed with interrupted 6-0 polypropylene sutures. 
The retroperitoneal layer was rcapproximated over 
the aorta and aneurysm, and the abdominal fascia 
was closed with a running suture of 0 polyglyconatc. 
The skin was closed with absorbable suture. 
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Table I. Summary of  18 animal experiments creating an infrarenal aortic aneurysm by use of a 
patch of small intestine sutured to the aorta ~ 
Dog no. Graft Completion angiogram Pressure Diffi. Outcome 
1 No Intact aneurysm N/A Kupture within 18 hours 
2 No Intact aneurysm N/A Rupmre within 18 hours 
3 No Intact aneurysm N/A Rupture within 30 hours 
4 No Intact aneurysm N/A Rupmre within 42 hours 
5 No Intact aneurysm (4% GA) N / A  Rupture within 5 days 
6 No Intact aneurysm (4% GA) N/A Rupture within 11 days 
7 No Intact aneurysm (1% GA) N/A Killed at 3 months, no mpmre 
8 Yes Incomplete exclusion 5 Rupmre within 3 days 
9 Yes Incomplete exclusion 5 Rupture within 4 days 
10 Yes Graft misplaced N/A Rupture within 4 days 
11 Yes Aneurysm cxcluded 35 Graft thrombosis at 6 days, no rupture 
12 Yes Aneurysm exduded 45 Graf* thrombosis at 4 days, no rupture 
13 Yes Aneurysm excluded 15 Killed at 100 days 
14 Yes Aneurysm excluded 75 Killed at 94 days 
15 Yes Aneurysm excluded 60 Killed at 92 days 
16 Yes Aneurysm excluded 60 Killed at 207 days 
17 Yes Aneurysm excluded 52 Killed at 196 days 
18 Yes Aneurysm excluded 44 Killed at 189 days 
Press. Diff, The difference in systolic pressure between the native aorta and the aneurysmal sac after exclusion; GA, glutaraldehyde. 
~The first seven animals did not undergo aneurysm exclusion, whereas the last 11 did. 
Postoperative management 
All animals were given intravenous antibiotics for 
24 hours after operation and oral antibiotics for 3 
days thereafter. Postoperarive analgesia was admin- 
istered intravenously during the first 24 hours with 
butorphanol tartrate or morphine. An oral diet was 
resumed 24 hours after surgery. Seven to 10 days 
after ancurysm exclusion, anteroposterior and latcral 
aortograms were obtained with the dogs under 
anesthesia. All animals surviving aneurysm exclusion 
were kept alive on a long-term basis and were killed 
at 3 or 6 months. All animals underwent aortography 
at the time of  euthanasia, and all animals underwent 
necropsy at the time of  sacrifice or spontaneous 
death. The aortic segment containing the aneurysm 
and graft was harvested at the time of death in all 
long-term survivors and preserved in i% formalde- 
hyde for histologic examination. 
Statistical comparison of survival data was per- 
formed by contingency table analysis. 
Histologic methods 
The abdominal aorta was perfusion fixed in situ 
with 4% buffered formalin. After excision, the aortic 
segment containing the stented graft was storcd and 
fixed in 10% formalin. Histologic sections were taken 
from five different levels of each specimen, including 
sections where only aorta and stents were present 
proximally and distally, sections where the aorta 
encirded the Dacron and stents proximally and 
distally, and scctions where the intestinal patch and 
aorta (aneurysm sac) encircled the Dacron graft 
without stents. The tissue was dehydrated with 
ethanol and infiltrated with glycol methacrylate 
compound. The tissue was mounted and cut on a 
Buehlcr Isomet low-speed saw with a diamond 
wafering blade (Buehler, Lake Bluff, Ill.). Sections 
were then mounted on petrograph slides and ground 
to 100 to 300 txm with a Buehler Minimet Polisher. 
A polishing cloth was mounted on the Minimet 
Polisher, and fine polishing was performed with 
Buehler's Metadi 9 txm aerosol spray diamond 
compound. The sections were then removed from 
the petrograph slides with acetone and remounted on 
standard slides for hematoxylin and eosin staining. 
RESULTS 
Four dogs with aneurysms created with tmtreated 
intestinal patches that did not undergo exclusion died 
within 18 to 42 hours after surgery (Table I). In all 
four animals massive retroperitoneal hemorrhage 
from jejunal patch rupture was documented at the 
time of  necropsy. Among the three dogs with 
aneurysms made of glutaraldehyde-treated homolo- 
gous intestine, two with intestinal patches preserved 
in 4%-glutaraldehyde for 48 hours died of aneurysm 
rupture at 5 and 11 days after surgery, respectively. 
One animal with an aneurysm made with intestinal 
patch preserved in 1% glutaraldehyde for 6 hours 
survived without rupture for 3 months until he was 
killed. 
In two animals the aneurysm exclusion was 
followed by graft thrombosis cansed by graft kinking 
at the time of deployment, which manifested as 
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Fig. 3. Aortogram of infrarenal aortic aneurysm created 
in dog by sumring patch of small intestine to longitudinal 
aortotomy (top). Completion aortogram after endovascu- 
lar exclusion of aneurysm with stented Dacron graft 
(bottom). 
paraplegia on the first and sixth postoperative day, 
respectively. In these two animals the completion 
angiogram revealed complete aneurysm exdusion, 
and the aorta-to-aneurysm pressure differential was 
35 and 45 mm Hg, respectively. Both animals were 
ldlled becanse of their paraplegia, and at the time of  
necropsy both dogs had thrombosed aneurysms 
without any evidence of  rupture. In three dogs, 
aneurysm exdusion was incomplete, as evidenced by 
opacification of  the aneurysm sac and lumbar arteries 
directly from a focal leak coming from the proximal 
neck observed in real time angiography. The aorta- 
to-aneurysm pressure differential in these three ani- 
mals was 0 to 5 mm Hg. These three dogs died at 3, 
4, and 5 days after surgery of  aneurysm mpture 
documented on necropsy. 
Successful aneurysm exclusion was followed by 
uneventful long-term survival in six dogs. These six 
animals showed perfect exclusion of  the aneurysm on 
completion angiography (Figs. 3 and 4), and their 
aorta to aneurysm sac pressure differential were 15, 
44, 52, 60, 60, and 75 mm Hg, respectively, with a 
mean pressure differential of  51 mm Hg. Survival 
was significantly bet-ter (p < 0.023) in the animals 
with successful aneurysm exclusion without throm- 
bosis (n = 6) compared with those animals with 
aneurysms made of  unaltered intestine without 
exclusion or with failed exclusion (n = 7). 
There was no evidence of  infection in any of  the 
animals in the study on the basis of  clinical status, 
macroscopic findings at the time of  autopsy, and 
histologic examination results. Aneurysm cultures, 
however, were not obtained. 
Pathology results 
The hismlogic changes associated with endovas- 
cular graft cxclusion of experimental aortic aneu- 
rysms were examined at five different levels of  the 
postmortem specimens of  three dogs killed at 3 
months and ofthree dogs killed at 6 months. All eases 
showed cross-sections ofvcssel wall with metal stents, 
Dacron mesh, or monofilament sutures. In the three 
6-month specimens and in two of  the 3-month 
spccimens, thc Dacron mesh was embedded in a 
fibrocellular proliferation present on both surfaces at 
all levels of cross-section (Fig. 5). Single fibroblasts 
were seen growing into, but not disrupting, the 
Dacron mesh. It was not possible m determinc 
whether the fibroblasts were growing from the lumi- 
nal or the abluminal surface of the Dacron or from 
both. The graft lumen in these five specimens was 
entirely patent. The thickness of  the fibrointimal pro- 
fiferation varied from 0.1 to 0.5 mm (mean thickness 
0.25 mm). A similar but thinner fibrointimal prolif- 
eration (range 0.05 to 0.2 mm, mean thickness 0.1 
mm), encased the metal stents. A cellular lining was 
seen on the lumenal surface overlying Dacron and 
stents, compatible with endothelial coverage. How- 
ever, staining for factor VIII or other method to 
identify endothelial cells was not done. Foreign body 
giant cell reäction was not associated with either Da- 
cron mesh or metal stents. In the region where the 
intestinal patch formed the aneurysm sac, two dis- 
tinct smooth muscle cell layers of  the intestinal mus- 
cularis propia were identifiable. The space between 
the Dacron and the intestine (aneurysm sac) was vir- 
mal and occupied by ä thin layer of  degenerating red 
blood cells and organizing scar, but no persistent 
thrombus was identified (Fig. 6). 
The thickness and cellularity of  the fibrointimal 
response encasing the Dacron was similar at all levels 
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Fig. 4. Infrarenal aortic specimen, removed while patent 3 months after successful exclusion 
with stented Dacron cndovascular graft. Note significant shrinkage of aneurysm sac relative to 
adjacent aorta, compared with size at implantation shown in Fig. 1. 
of graft sections and not different between the 3- and 
ó-month specimens. 
In one of the 3-month specimens, the proximal 
portion of the graft lumen revealed a tight stenosis 
(90%) occluded by a loose fibromyxoid proliferation 
consistent with organizing thrombus without fibro- 
muscular hyperplasia. The remainder of the distal 
graft had a completely patent lumen. However, and 
in sharp contrast with the other five specimens, the 
lumenal surface contained no fibrointimal prolif- 
eration, and the cellular lining was discontinuous 
and sparse. In many areas Dacron mesh was covered 
by a thin layer of fibrin, platelcts, and red blood 
cells. Fibrocellular proliferation was present encas- 
ing the external surface of the Dacron in this 
specimen. 
D I S C U S S I O N  
Successful treatment of patients with AAA is 
measured by the complication-free long-term sur- 
vival of" these patients. In selected centers, the 
mortality rate for surgical repair of AAA is less than 
5%, with a long-term complication rate less than 
3%. ~° Adthough cndovascular repair of AAA may 
rcduce the pcriopcrative morbidity and mortality rate 
for the procedure, mainly by minimizing the cardio- 
vascular risks of the operation, the efficacy in 
preventing aneurysm rupture is yet to be proven, and 
a reduction in the long-term complications remains 
to be seen. This uncertainty is i[iustrated by a recent 
report by Lunsdem n describing the rupture of an 
aneurysm in a patient a few days after endovascular 
exclusion. Accordingly, the most important qualities 
of any endovascular device designed for the exclusion 
of AAA are effectiveness in preventing rupture and 
freedom from short- and long-term complications. 
These qualities depend on the performance of the 
endovascular graft-delivery system and maybe more 
importantly on the deployment technique. These 
factors need to be evaluated extensively before these 
devices are widely used in patients. If endovascular 
repair of  aortic aneurysms is franght with a signifi- 
cantly higher long-term complication rate and de- 
creased graft patency rate, it would be difficult to 
justify its use in patients with acceptable risk for 
conventional operative repair. The early phase in the 
widespread clinical application of these devices, 
whenever it takes place, can produce disappointing 
results if the appropriate steps in their evaluation and 
in the acquisition of the deployment ski[is are not 
planned carefully. Animal testing of endovascular 
grafts and of their placement technique is an essential 
step for the successful clinical application of these 
devices. 
Previous experimental studies of transfemoral 
aortic aneurysm exclusion with endovascular grafts 
focused on the technical feasibility of performing this 
procedure in large animals harboring surgically 
created aortic aneurysms in some instances, 1'35 or in 
normal animal aortas in others. 2,s Some investigators 
uscd aneurysm models made of Dacron, sewing 
patches to the anterior wall of the aorta ~ or interpos- 
ing fusiform Dacron cylinders in the infrarenal 
aorta. 4'6 Mirich et al. 3 created aortic aneurysms 
without using prosthetic material by balloon dilation 
of the aorta after surgical stripping of the tunica 
mcdia. Nonc of these aneurysm models, however, 
have been shown to have any tendency for rupture. 
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Fig. 5. Histologic section (low power) ofproximal aspect 
of excluded experimental aortic aneurysm at 3 months after 
implantation. Dacron and stents are covered with fibrocel- 
lular layer on lumenal surface. 
Furthermore, aortic aneurysm models without 
patent lumbar arteries 1,4,6 are unrealistic because the 
absence of branches facilitates thrombosis of the 
aneurysm sac eren if a leak would exist at either end 
of  the graft after endovascular exclusion. Therefore 
these models, although useful for the evaluation of 
the delivery system and graft deployment technique, 
cannot evaluate the efficacy of any particular device in 
preventing aneurysm rupture. 
The various endovascular devices currently un- 
dergoing evaluation for exclusion of AAA in human 
beings are rar from ideal and invariably will undergo 
modifications for improvement, whereas new devices 
will become available. Future new devices and 
modified versions of the available ones therefore will 
require animal testing before their use in human 
beings. Our aneurysm model may serve this purpose. 
It permits creating an aneurysm at any level of the 
aorta to test the deployment ofany available or future 
endovascular graft and also can provide an immediate 
answer to the question of whether it can prevent 
aneurysm rupture. Preservation of the native aortic 
wall with patent lumbar arteries in the posterior 
aspect of the aneurysm sac and avoiding the use of 
prosthetic material provides a more realistic model to 
study the interaction between the endovascular 
stented graft and the host native tissues. 
In accord with the recommendations of the Joint 
Council of the Society for Vascular Surgery/Inter- 
national Society for Cardiovascular Surgery Ad Hoc 
Committee on Reporting Standards in Vascular Sur- 
gery, n we used male dogs in our model. Our aneu- 
rysm model of untreated intestinal patch showed a 
constant tendency for rupture within a few days ofits 
creation that occurred in all animals whose aneurysms 
were not excluded and in all those in whom the exclu- 
sion failed. The absence of aneurysm rupture in all 
the animals with successful exclusion demonstrates 
the effectiveness of the endovascular device used in 
OHr study. 
Modification of the intestinal patch with glutar- 
aldehyde may delay or prevent rupture of the 
experimental aneurysm. The mechanical characteris- 
tics of glutaraldehyde-treated tissue depend on the 
concentration and time of exposure. 13 Although our 
experience was very limited, however, we observed 
that intestine exposed to higher concentrafions of 
glutaraldehyde (4%) for longer periods (over 48 
hours) acquired rubberlike consistency and was stift, 
difficult to suture, and likely to tear under tension. On 
the other hand, we observed that patches exposed to 
lower concentrations of glutaraldehyde (1%) for 
shorter periods (6 hours or less) had much better 
surgical handling. Such was the case in our third 
aneurysm created with glutaraldehyde-treated intes- 
tinal patch, which did not rupture, maintaining its 
aneurysmal shape for more than 3 months until the 
animal was killed. Further study is required to 
evaluate the use of glutaraldehyde-preserved intestine 
to create chronic aneurysms. 
Graft migration after deployment is a concern 
with the use of endovascular devices. It did not occur, 
however, in any of our animals that survived long 
term, wherein the stent and graft remained anchored 
to their original aortic position bridging the aneu- 
rysm. This demonstrated the effectiveness of the 
stents used in our study in anchoring the graft to the 
aorta. In human beings, dilation of the aortic neck 
after aortic aneurysm repair is common, and its 
potential effect on dislodging the proximal steht with 
subsequent graft migration is a distinct possibility. In 
this regard, the effect of aortic enlargement on 
stent-graft stability requires further study in the 
laboratory. 
Large-animal aneurysm models permit evaluation 
of the long-term patency of  endovascular grafts and 
serve as a training ground before they are used in 
patients. In our experience, failed exclusions leading 
to aneurysm rupture occurred during the early part of 
the study. In a similar way, graft kinking, which led 
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Fig. 6. Histologic section of mid portion (aneurysm sac) of excluded experimental aortic 
aneurysm at 3 months after implantation. Space between Dacron graft and intestine (aneurysm 
sac) is virmal and occupied by thin layer of degenerating red blood cells and organizing scar, 
but without pêrsistent thrombus. 
to graft thrombosis in two animals in spite ofsuccess- 
ful aneurysm exclusion, also occurred during the frst  
part of  our study. These technical problems during 
our early laboratory experience suggest that graft pa- 
tency of  endovascular devices may be curtailed by the 
technical sldtls in their deployment and illustrate that 
the learning curve involved in the proficient use of  
endovascular devices is likely to have an impact on 
their effectiveness and compfication rate. It appears 
advisable therefore that a significant animal cxperi- 
ence is acquired before engaging in the use of  endo- 
vascular grafts for the exclusion of  aneurysms in hu- 
man beings. The technical demands involved in the 
use of  bifurcated grafts for the exclusion of  aortic 
aneurysms involving the iliac arteries are greater than 
those of  straight grafts, thcrcfore the learning curve 
required for their proficient use is likely to be longer. 
It is important to point out  the little resemblance of  
this and other aortic aneurysm models with the fea- 
tures of  AAA in human beings. The technical and 
physiologic problems encountered during endovas- 
cular repair of  AAA in human beings may be quite 
different from those found in animals, and will vary 
depending on the anatomy of the patient and type of  
endovascular device used. 
Histologic examination of  our endovascular Da- 
cron grafts revealed that incorporation of  the graft to 
the luminal and abluminal surfaces was complete at 3 
months after implantation, occurring in a similar 
fashion as that described in surgically anastomosed 
Dacron prostheses. ~4,1s It also showed that the 
metallic stents were covered by the same cellular layer 
as the Dacron fabric. The absence ofluminal coverage 
in one of  our specimens with a tight stenosis in the 
proximal aspect of  the graft suggests that ceUular 
covcrage of  the lumenal surface may occur as a 
proliferative phenomenon initiated in the proximal 
native vessel that extends distally into the graft. 
In summary, we have developed a simple an- 
eurysm model with a predictable tendency for 
rupture and proved the efficacy of  an endovascular 
stented Dacron graft in preventing aneurysm mp_ 
rare. Endovascular Dacron prostheses anchored to 
the canine aorta with metallic stents maintain long- 
term patcncy without migration and experience 
rapid incorporation into the surrounding tissues, 
with complete fibrocellular coverage of  the graft and 
stents. This aneurysm model is useful for the evalu- 
ation of  the efficacy in preventing mpture of  en- 
dovascular prostheses and of  their long-term effects 
after implantation. 
Special thanks to Ruhl R. Alexander, RTR, and Tad W. 
Jones RTR, for their technical support in imaging smdies, 
to Jose I. Ferreiro for help in hemodynamic data acquisi- 
tion, and to the Meadox Corporation for supplying 
prosthetic material. 
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D I S C U S S I O N  
Dr. Frank  I. Veith (Bronx, N.Y.) .  This study ad- 
dresses the crucial question: "Will endovascular stented 
grafts prevent aneurysm rupture?" Moreover, it does so in 
a cleverly designed animal model in which rupture occurs 
within a few days in the absence of  some effective 
prophylactic treatment. This model also has the advantage 
of  preserving patent branches like the inferior mesenteric 
arteries and the lumbar arteries that feed into the aneurysm. 
This kind ofanimal model validation is sorely needed in this 
field. However, Dr. Criado's model is still not perfect for 
proving that a stented graft will prevent aneurysm rupture 
in human beings for three reasons. First, if a stented graft 
in a patient with an aneurysm has a leak, the aneurysm may 
rupture late because the aortic pressure is transmitted to the 
aneurysm wall. Diseased human vessels may be more prone 
to such leaks than normal dog arteries. Indeed they are. 
Second, even if no leak is seen with angiography and the 
leak is sealed with a clot, the systolic arterial pressure may 
still be transmitted to the aneurysm wall, and it may 
rupture. This has occurred in several of  Dr. Parodi's human 
cases. Third, if the stented graft is weil seated into clot or 
diseased, normal-sized aorta, that aorta may enlarge, and 
the graft may develop a leak that may lead to rupture. This 
too has been observed clinically by Dr. Parodi and in one 
of  our cases. 
This leads to two conclusions. The first is that we need 
a model in which pressure within the aneurysm sac can be 
measured over the long term. The second and more 
disturbing conclusion is that there may be no totally valid 
animal model that will predict the ability of  an endovascular 
stented graft to prevent aneurysm rupture. We will just 
have to find that out in patients with aneurysmal disease. 
Even in that perfect model it will take many years before we 
know because even moderate-size aneurysms, if untreated, 
may take many years to rupture. 
Dr. Criado has performed one of  the few available 
studies that show how endovascular grafts heal within an 
aneurysm. His observation that endothelium develops on 
these grafts is intriguing. We have also observed endothe- 
lialization of  a few endovascular grafts placed within 
previously occluded human arteries (J VASC SURG 1995; 
21:595-604). 
What is the source of  pressure within the excluded 
aneurysm? When all the branches are thrombosed, it is not 
clear how this pressure is generated. 
Dr.  Enrique Criado. I agree with the limitations of  
our model and with the differences between this animal 
model and what may happen in human beings. However, 
we submit this model for the evaluation of  potential devices 
that will be appearing in the market in the future. 
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With regard to the potential enlargement of  the arteries 
that may dislodge the stems and graft, we are now working 
in the laboratory to study further the effect of  aneurysm 
neck enlargement on the stability of  the graft. We are doing 
that in a pig growth model. 
With regard to pressure data, our pressures were 
measured acutely while the aneurysm was still not 
thrombosed; therefore there was still a pressure transmis- 
sion in ~he aneurysm sac at the end of  the procedure. 
However, since the completion of  this study, Dr. Marston 
and I have measured aneurysm pressures for several hours 
in acute experiments in a similar model but with large 
patent branches, and we found that the pressure dropped 
very quickly during the first few hours to equalize the 
pressure in the sac to that of  the major branches, and there 
was no flow from the distal branches into the aneurysm. 
Dr. Mitchell H.  Goldman (Knoxville, Tenn.). How 
long were these intravascular grafts and are you sure the 
endothelialization is not just the pannus ingrowth from the 
end? 
Dr. Criado. They were 7 cm, and they were completely 
incorporated from proximal to distal, and we cut these 
grafts at five different points with fibrointimal incorpora- 
tion. Endothelialization was complete at all levels. 
Dr. G. Patrick Clagett (Dallas, Texas). Where was the 
site of  rupture in the patch? 
Dr. Criado. Almost all of  the animals had rupture in 
the middle aspect of  the patch. A couple of  the grafts 
ruptured at the anastomotic site by where the stitches were 
placed. 
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